YILING PHARMACEUTICAL

002603

15.380.65% ( -0.10 )

Delay Closed: Nov 13, 15:00:00

Q3 2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: YILING PHARMACEUTICAL(002603) the Revenue is 1.894 B (+3.62%);the EBIT is 408.38 M (+2.04%);the EPS is 0.203 (+2.06%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

1.89B3.62%

----

----

EBIT

0.41B2.04%

----

----

EPS

0.20272.06%

----

----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateApr 29, 2027

Estimate Revenue8.175 B

Estimate EBIT1.803 B

Estimate EPS0.885

Revenue

ActualEstimateUnit: CNY

Quarterly

EBIT

ActualEstimateUnit: CNY

Quarterly

Net income

ActualEstimateUnit: CNY

Quarterly

EPS

ActualEstimateUnit: CNY

Quarterly